Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06676904 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neonatal Platelet Transfusion Threshold Trial

Study acronym: NeoPlaTT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised at 2 of 20 sitesv9
  2. Minor Site details revised at 5 of 20 sitesv8
  3. Minor Start date changed from estimate of Jun 30, 2025 to Jun 13, 2025
    • Secondary endpoints: details revised at 3 of 7 entries
    • Site details revised at 10 of 20 sites
    v7
  4. Minor Start date: Jun 1, 2025 to Jun 30, 2025v6
  5. Minor Study description expanded, about 4 wordsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Mar 28, 2025 to Jun 1, 2025
    • Site details revised at 20 of 20 sites
    v4
  2. Notable Start date: Feb 7, 2025 to Mar 28, 2025
    • Site contacts updated at 8 of 20 sites
    v3
  3. Notable Primary completion date: Feb 9, 2032 to Jan 31, 2031
    • Study completion date: Jul 12, 2032 to Apr 30, 2031
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Trial Details
NCT Number NCT06676904
Lead Sponsor NICHD Neonatal Research Network
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Thrombocytopenia, Neonatal, Platelet Transfusion, Infant, Newborn, Diseases, Infant, Extremely Low Birth Weight, Infant, Small for Gestational Age, Thrombosis
Related terms Infant, Newborn, Diseases, Thrombocytopenia, Thrombosis
Enrollment 2,433 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov